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Each month, Chemistry & Biology Select highlights a selection of research reports recently
published in other journals. These highlights are a snapshot of interesting research done across
the field of chemical biology, and this month’s Select features a new approach to targeting Ras
signaling, a discovery of a nucleoside analog as a protective agent against filovirus diseases, an
application of a selective inhibitor of deubiquitinase complex USP1:UAF1 for functional studies,
and evidence that acetyl-CoA regulates autophagy.Small-molecule modulators of SOS (light blue) are
found to bind a hydrophobic cavity located close to
the region of Ras (orange) involved in interactions
with the SOS catalytic domain (gray). Image
courtesy of S. Fesik.Targeting Ras Signaling via SOS
The Ras family of small GTPases controls a number of signaling pathways
important for cell growth and survival and is intimately linked to human
cancers. Ras, a member of the family, has been the focus of many anti-
cancer drug development efforts, because it is the most common human
oncogene. Unfortunately, Ras is a difficult protein to target and a viable
clinical drug candidate is yet to emerge. Given that Ras activity is
modulated by a number of proteins, an alternative strategy for exerting
effects on Ras signaling would be to target those binding partners. This is
the approach pursued by Burns et al. (2014), who focus on discovery of
small-molecule modulators of SOS, a Ras-specific guanine nucleotide
exchange factor (GEF) that activates Ras.
Burns et al. synthesize a series of compounds that activate nucleotide
exchange in an SOS-dependent manner. Structures of Ras:SOS:Ras com-
plex bound to the compounds reveal that the compounds bind to a hydro-
phobic pocket on SOS that is in close proximity to the region of Ras critical
for binding thecatalytic domain of SOS.The authors validate that this pocket
is functionally important formediating effects of the smallmolecules through
site-directed mutagenesis and activity measurements. When these small
molecules are used in cell-based assays, their application leads to an increase in levels of Ras-GTP, but, counterintuitively,
increased levels of Ras-GTP don’t lead to an increase in Ras-mediated signaling in PI3K pathway and result in a biphasic
perturbation of MAPK pathway. Surprisingly, the treatment of both WT and mutant Ras cancer cells with the compounds
inhibits cell proliferation and growth. Although there are number of open questions regarding how the binding of these small
molecules to Ras:SOS:Ras induces the observed cellular effects, it seems clear that Burns et al. add potentially valuable tools
for specifically perturbing an important node inRas signaling anddescribe the basis of an alternative strategy for targetingRas.
Burns et al. (2014). Proc. Natl. Acad. Sci. USA. Published online March 4, 2014. http://dx.doi.org/10.1073/pnas.1315798111.Deadly Hemorrhagic Fevers: A Therapeutic Option Emerges
Filoviruses are causative agents of hemorrhagic fevers in humans and some of the deadliest pathogens known, with fatality
rates in some cases exceeding 90%. The Ebola and Marburg viruses are the two best known filoviruses, although the list of
viruses classified in the Filoviridae family is growing and with it the need to develop therapeutic agents with broad-spectrum
activity.
A recent report by Warren et al. describes the synthesis and characterization of one such agent: a nucleoside analog,
BCX4430. BCX4430 is designed to result in premature termination of viral RNA transcription and replication by undergoing
transformation into phosphorylated-BCX4430, which is then incorporated into the nascent RNA and prevents further RNA
synthesis. The authors show evidence that supports this mechanism of action, as well as evidence that BCX4430 is selective
for incorporation into viral RNA without affecting human RNA and DNA. Besides being active against the Filoviridae family,
BCX4430 is active against other RNA viruses through the same mechanism. Furthermore, Warren et al. observe that
BCX4430 protects mice against Ravn virus infection as well as against lethal Ebola and Rift Valley fever virus challenges.
Similarly, BCX4430 protects guinea pigs in Marburg virus disease models. Finally, studies of BCX4430 efficacy done in
crab-eating macaques infected with the lethal dose of Marburg virus show a dramatic increase of survival rates, from 0%
to above 100%when BCX4430 is administered within 48 hr of infection. Overall, BCX4430 seems to be a highly efficient agent
that is well tolerated, nonmutagenic, and without adverse reactions or toxicity. This is an interesting development in the
disease area that has been lacking usable treatment options.
Warren et al. (2014) Nature. Published online March 2, 2014. http://dx.doi.org/10.1038/nature13027.Chemistry & Biology 21, March 20, 2014 ª2014 Elsevier Ltd All rights reserved 307
Small-molecule chemical probe, ML323, binds and inhibits the
USP1:UAF1 deubiquitinase complex, leading to insights about
the connection between deubiquitination and two DNA
damage response pathways; Fanconi anemia (FA) and DNA
translesion synthesis (TLS). Image courtesy of Z. Zhuang and
D. Maloney.
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Levels of protein ubiquitination are regulated by two classes of
enzymes: ubiquitin ligases that attach ubiquitin (ubq) molecules
to the target protein and deubiquitinases that remove the attached
ubqs. Although originally appreciated for its role in targeting pro-
teins for proteasomal degradation, ubiquitination is now accepted
to play a nondegradative regulatory role.
Liang et al. describe a small-molecule chemical probe, ML323,
which inhibits USP1:UAF1 deubiquitinase complex with high
selectivity. This allows them to examine the role of USP1:UAF1
in two pathways important for DNA damage response: Fanconi
anemia (FA) and DNA translesion synthesis (TLS). They demon-
strate that ML323 is a potent, reversible, selective, and most likely
allosteric inhibitor of USP1:UAF1 in vitro and in cells. The use of
ML323 results in inhibition of USP1:UAF1 and, thus, inhibition of
deubiquitination of two known target proteins of USP1:UAF1:
PCNA, involved in TLS pathway, and FANCD2, with the central
role in FA pathway. Under conditions that lead to UV-induced
DNA lesion, cyclobutane pyrimidine dimer (CPD), ML323 causes
a decrease in TLS mediated by Polh and sensitizes cells to DNA
damage, which argues for the role of USP1:UAF1 and PCNA
deubiquitination in this process. When used in combination with
cisplatin, ML323 exhibits a synergistic effect resulting in sensitiza-
tion of cells resistant to cisplatin treatment. The authors provide
evidence that this effect is at least in lare part due to ML323-
mediated inhibition of USP1:UAF1 deubiquitination of FANCD2.
In conclusion, the probe compound Liang et al. describe confirms
the central role of deubiquitination in DNA damage response and
illustrates the power of selective chemical probes to open a
window into a better understanding of mechanistic details in
complex biological pathways.
Liang et al. (2014) Nat. Chem. Biol. Published online February 16,
2014. http://dx.doi.org/10.1038/nchembio.1455.Acetyl-CoA: Jack of All Trades, Master
of. AutophagyAcetyl coenzyme A (Ac-CoA) is one of the core molecules of cellular metabolism, because it is directly involved in the citric
acid cycle, a link between fatty acid and carbohydrate metabolism, and the metabolism of amino acids. Additionally, Ac-CoA
is the source of an acetyl group for protein acetylation, which regulates different cellular processes.
In their recent work, Marin˜o et al. perform metabolomic analysis of starved cells and identify Ac-CoA as one of the
metabolites that is significantly depleted under starvation conditions. They follow up on this observation to show that the
decrease of Ac-CoA is accompanied by the global decrease in acetylation levels of cytosolic proteins and an autophagic
response. The link between starvation, metabolism, and autophagy is well established; however, the relationship between
Ac-CoA and autophagy has not been reported previously. Marin˜o et al. show that when levels of Ac-CoA are maintained
during starvation, either by supplementation of Ac-CoA precursors or targeted increase in Ac-CoA production, the autophagy
is suppressed and the level of cytosolic protein acetylation is maintained. The authors find that the inverse is true as well and
that depletion of Ac-CoA by interfering with its production induces autophagy. Further analysis establishes that cytosolic
Ac-CoA is the repressor of autophagy and that acetyltransferase p300 (also known as EP300) is required to mediate this
effect. The authors suggest that p300might be a sensor for Ac-CoA, transforming information about the availability of Ac-CoA
into specific acetylation of different protein targets, thus activating or repressing autophagy. Although the mechanistic details
are yet to be determined, the study reveals that manipulation of Ac-CoA levels can be used to regulate autophagy, which is an
insight with clinical implications, especially for treatment of obesity and age-associated pathologies.
Marin˜o et al. (2014) Mol. Cell. 6, 710-725.
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